These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2087569)

  • 1. Paranoid conditions seen in psychiatric medicine.
    Webb W
    Psychiatr Med; 1990; 8(4):37-48. PubMed ID: 2087569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic value of clinical scales used in depression and paranoid syndromes].
    Jaroszyński J; Bokiewicz M; Charazińska E; Stanikowska I
    Psychiatr Pol; 1976; 10(3):233-8. PubMed ID: 951444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Difficulties in the classification of paranoid disorders].
    Grzywa A; Kucharska-Pietura K; Karakuła H
    Wiad Lek; 1999; 52(3-4):186-95. PubMed ID: 10499031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of paranoia and suspiciousness.
    Kirkpatrick B; Amador XF
    Biol Psychiatry; 1995 Oct; 38(8):496-7. PubMed ID: 8562660
    [No Abstract]   [Full Text] [Related]  

  • 5. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case report of paranoia--affective paraphrenia or schizophrenia?].
    Bräunig P
    Nervenarzt; 1990 Nov; 61(11):684-7. PubMed ID: 2290453
    [No Abstract]   [Full Text] [Related]  

  • 7. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective assessment of degree of psychiatric impairment: is it possible?
    Nussbaum K
    Johns Hopkins Med J; 1973 Jul; 133(1):30-7. PubMed ID: 4146233
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in mental status findings among subcategories of schizophrenia.
    Ohlms D; Brown ML; Altman H; Sletten IW
    Dis Nerv Syst; 1972 Mar; 33(3):187-91. PubMed ID: 5022454
    [No Abstract]   [Full Text] [Related]  

  • 10. MMPI scales vs interviewer ratings of paranoia.
    Harris RJ; Wittner W; Koppell B
    Psychol Rep; 1970 Oct; 27(2):447-50. PubMed ID: 4394978
    [No Abstract]   [Full Text] [Related]  

  • 11. Catatonia: its diagnostic validity.
    Hearst ED; Munoz RA; Tuason VB
    Dis Nerv Syst; 1971 Jul; 32(7):453-6. PubMed ID: 5570414
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodological problems in follow-up studies of paranoid psychoses.
    Opjordsmoen S; Retterstøl N
    Psychiatr Dev; 1985; 3(2):187-204. PubMed ID: 4048146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS).
    Green CE; Freeman D; Kuipers E; Bebbington P; Fowler D; Dunn G; Garety PA
    Psychol Med; 2008 Jan; 38(1):101-11. PubMed ID: 17903336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds.
    Ostling S; Börjesson-Hanson A; Skoog I
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):999-1004. PubMed ID: 18056818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphic mental disorders in the course of Lyme borreliosis--case study].
    Helon B; Tłuczek TW; Buczyjan A; Adamczyk-Helon A; Wojnarowicz M; Mikuła R; Ciciński P; Bojarska J
    Psychiatr Pol; 2009; 43(3):353-61. PubMed ID: 19725428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 17. [Consistency in the evaluation of mental status of patients with diagnosed delusional schizophrenia and depression].
    Rzewuska M; Górski M
    Psychiatr Pol; 1990; 24(6):12-8. PubMed ID: 2131479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset.
    Tonkonogy JM; Geller JL
    Neuropsychiatry Neuropsychol Behav Neurol; 1999 Oct; 12(4):230-5. PubMed ID: 10527107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A series of multicentric pilot trials with pimozide in psychiatric practice. IV. Pimozide in the treatment of patients with paranoid symptomatology.
    Amery W; Boom AJ; Huisman NG; Kuipers H; van der Wiel HJ; Reyntjens A
    Acta Psychiatr Belg; 1972 Nov; 72(6):677-84. PubMed ID: 4679634
    [No Abstract]   [Full Text] [Related]  

  • 20. Is paranoid status prognostic of good outcomes? It depends.
    Salinas JA; Paul GL; Newbill WA
    J Consult Clin Psychol; 2002 Aug; 70(4):1029-39. PubMed ID: 12182266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.